Literature DB >> 27232653

Cell-SELEX-based selection and characterization of a G-quadruplex DNA aptamer against mouse dendritic cells.

M Moghadam1, M Sankian2, K Abnous3, A Varasteh4, S M Taghdisi5, M Mahmoudi6, M Ramezani7, Z Gholizadeh8, A Ganji9.   

Abstract

Targeting of dendritic cells (DCs) by aptamers increases antigen capture and presentation to the immune system. Our aim was to produce aptamers against DC molecules using the cell-SELEX procedure. For this purpose, 18 rounds of cell-SELEX were performed on mouse macrophage J774A.1 and CT26 as target and control cells, respectively. The selected aptamers were truncated and their binding to mouse macrophages, and immature and mature DCs analyzed. Two macrophage-specific aptamers, Seq6 and Seq7, were identified. A truncated form of Seq7, Seq7-4, 33 nucleotides in length and containing the G-quadruplex, bound macrophages and immature DCs with KD values in the nanomolar range. We anticipate that Seq7-4 has potential as a therapeutic tool in targeting of mouse macrophages and immature DCs to efficiently improve different immunotherapy approaches.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aptamers; Cell-SELEX; DNA aptamer; G-quadruplex aptamer; J774A.1; Mouse dendritic cell targeting

Mesh:

Substances:

Year:  2016        PMID: 27232653     DOI: 10.1016/j.intimp.2016.04.042

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  3 in total

1.  Aptamers as quality control tool for production, storage and biosimilarity of the anti-CD20 biopharmaceutical rituximab.

Authors:  Sabrina Wildner; Sara Huber; Christof Regl; Christian G Huber; Urs Lohrig; Gabriele Gadermaier
Journal:  Sci Rep       Date:  2019-02-01       Impact factor: 4.379

2.  Identification of G-quadruplex anti-Interleukin-2 aptamer with high specificity through SELEX stringency.

Authors:  Mohsen Momeni; Kazem Mashayekhi; Jamshid Gholizadeh Navashenaq; Mojtaba Sankian
Journal:  Heliyon       Date:  2022-06-15

3.  Rituximab-specific DNA aptamers are able to selectively recognize heat-treated antibodies.

Authors:  Michael Kohlberger; Sabrina Wildner; Christof Regl; Christian G Huber; Gabriele Gadermaier
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.